Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways

Published 2017 View Full Article

Authors

Keywords

Anti-androgen, Prostate cancer, Cell junctions, Androgen receptor, Akt, ERK1/2

Journal

TOXICOLOGY IN VITRO

Volume 40, Issue -, Pages 324-335

Publisher

Elsevier BV

Online

2017-02-03

DOI

10.1016/j.tiv.2017.01.019

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now